TABLE 1.
Association between circRHOT1 expression and clinicopathologic features
| Clinicopathologic feature | CircRHOT1 expression | P value | ||
|---|---|---|---|---|
|
Negative group N = 6 (%) |
Positive group N = 22 (%) |
|||
| Age (y) | ||||
| 65.92 ± 11.33 | 69.33 ± 16.48 | 65 ± 9.81 | T = −0.825 | 0.417 |
| Sex | ||||
| Male | 4 (66.67) | 15 (68.18) | 0.99 | |
| Female | 2 (33.33) | 7 (31.82) | ||
| Stage | ||||
| IIA | 4 (66.67) | 7 (31.82) | 0.174 | |
| IIB or III | 2 (33.33) | 15 (68.18) | ||
| Size (cm3) | ||||
| 44.18 ± 133.78 | 26.2 ± 25.27 | 49.09 ± 150.8 | Z = −0.617 | 0.654 |
| Lymphatic metastasis | ||||
| Yes | 1 (16.67) | 16 (72.73) | 0.022* | |
| No | 5 (83.33) | 6 (27.27) | ||
Independent‐samples t test was conducted to evaluate the circRHOT1 expression with age; Fisher's exact test was used to evaluate the circRHOT1 expression with sex, tumour stage and lymphatic metastasis; Mann‐Whitney test was applied to evaluate the circRHOT1 expression with tumour size.
*
P < 0.05